tykhr
sign in
free sign up
XTL Biopharmaceuticals Ltd ADR
Biotechnology
Healthcare
XTLB
545 M shares
NASDAQ US
traded
08 May 2025
listed
no
open
1.29
52 week high
2.98
high
1.34
52 week low
1.32
low
1.27
growth
-48.05 %
previous Close
1.36
P/E ratio
market cap
10.24 M
div yield
0
usd
Mar 2024
qoq
revenue
0.00 %
net incoming
485 K
170.00 %
eps
0.00 %
270.83 %
eps surprise
0.00 %
net profit margin
48500000.00 %
0.00 %
operating incoming
-175.00 K
-87.00 %
net change in cash
0.00 %
cash on hand
1.07 M
-23.77 %
cost of revenue
0.00 %
top